StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.26−0.14 (-4.12%)

Close on Nov 17, 2026Market cap $24.02MP/E –Yield –

Immutep operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -A$55.46M. The highest annual figure on record is -A$7.78M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$55.46M–
FY2025Jun 30, 2025-A$62.05M–
FY2024Jun 30, 2024-A$34.82M–
FY2023Jun 30, 2023-A$35.36M–
FY2022Jun 30, 2022-A$30.23M–
FY2021Jun 30, 2021-A$17.64M–
FY2020Jun 30, 2020-A$10.84M–
FY2019Jun 30, 2019-A$15.29M–
FY2018Jun 30, 2018-A$7.78M–
FY2017Jun 30, 2017-A$8.51M–
FY2016Jun 30, 2016-A$11.31M–

More Immutep figures

See a number that looks wrong?